Johnson & Johnson consumer arm valued at…
Kenvue, the consumer arm of healthcare giant Johnson & Johnson, was valued at $41bn in an upsized…
Browsing Tag
41bn
Bristol-Myers Squibb to acquire cancer drugmaker…
Bristol-Myers Squibb has agreed to acquire Turning Point Therapeutics for $4.1bn in the latest in a series…